glp-1 blood clots Can Weight Loss Injections Cause Clots? Evidence and Safety GLP1 Medications and Blood Clot

The experiments have different results, and the effects vary between different individuals

doi: 10.1016/s0140-6736(23)00023-5

The following is a summary of documented tissue systems from peer-reviewed literature: This cross-tissue activity profile is directly attributable to the fact that its primary mechanisms VEGFR2-driven angiogenesis and NO system modulation are not tissue-specific

In these situations, there is "reasonable probability that the use of or exposure to a product will cause serious adverse health consequences or death." Class II recalls are for drugs that may cause temporary or medically reversible adverse health consequences or where use of the product is unlikely to result in serious adverse health consequences